186 filings
DEF 14A
BFRI
Biofrontera Inc
Definitive proxy
17 Apr 24
5:21pm
8-K/A
BFRI
Biofrontera Inc
3 Apr 24
Other Events
5:00pm
8-K
BFRI
Biofrontera Inc
26 Mar 24
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
4:45pm
DEF 14A
BFRI
Biofrontera Inc
Definitive proxy
20 Mar 24
8:41pm
S-1/A
BFRI
Biofrontera Inc
IPO registration (amended)
19 Mar 24
8:44pm
8-K
hxtfqgo xow1hh
15 Mar 24
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
5:20pm
D
i9k m2gigedg50d
5 Mar 24
$8.00 mm in equity / options / securities to be acquired, sold $8.00 mm, 8 investors
5:20pm
8-K
k3cv4te
23 Feb 24
Biofrontera Inc. Announces Closing of Private Placement of Up To $16.0 Million priced at market per Nasdaq rules
9:26am
8-K
y49y1 5bzd
20 Feb 24
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
9:37am
RW
61r tne8s0hj6
20 Feb 24
Registration withdrawal request
7:55am
8-K
pgt6xykat5pjx
12 Feb 24
Other Events
9:39pm
8-K
08e0xsq idm
5 Feb 24
Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for AmeluzĀ® to Permit Up to Three Tubes per Use
5:25pm
8-K
ik9p5m4464ua0qa n5b
2 Feb 24
Entry into a Material Definitive Agreement
4:30pm
8-K
cg1yh
25 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
mke6 bv1b8pjl1a8el
11 Jan 24
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023
4:40pm